X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
oncology (21) 21
index medicus (20) 20
cancer (17) 17
female (15) 15
adult (12) 12
male (12) 12
chemotherapy (11) 11
middle aged (11) 11
aged (10) 10
metastasis (9) 9
prostate cancer (9) 9
survival (9) 9
breast cancer (8) 8
care and treatment (8) 8
tumors (8) 8
docetaxel (7) 7
risk factors (7) 7
biomarkers (6) 6
breast neoplasms - drug therapy (6) 6
prognosis (6) 6
research (6) 6
article (5) 5
hematology, oncology and palliative medicine (5) 5
metastases (5) 5
neoadjuvant therapy (5) 5
retrospective studies (5) 5
treatment outcome (5) 5
adolescent (4) 4
animals (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
biomarker (4) 4
breast neoplasms - pathology (4) 4
cell line, tumor (4) 4
child (4) 4
gene (4) 4
genetic aspects (4) 4
mice (4) 4
neoadjuvant chemotherapy (4) 4
neoplasm staging (4) 4
plasma dna (4) 4
prostate (4) 4
risk (4) 4
therapy (4) 4
urology & nephrology (4) 4
young adult (4) 4
adjuvant treatment (3) 3
aged, 80 and over (3) 3
analysis (3) 3
androgen receptor (3) 3
angiogenesis (3) 3
antineoplastic agents - therapeutic use (3) 3
bevacizumab (3) 3
bioindicators (3) 3
biomarkers, tumor - genetics (3) 3
breast (3) 3
breast neoplasms - mortality (3) 3
cabazitaxel (3) 3
castration-resistant prostate cancer (3) 3
cells (3) 3
clinical trials (3) 3
development and progression (3) 3
disease-free survival (3) 3
enzalutamide (3) 3
follow-up studies (3) 3
gene expression (3) 3
mice, inbred c57bl (3) 3
patients (3) 3
progression (3) 3
prostatic neoplasms - genetics (3) 3
prostatic neoplasms - pathology (3) 3
pten phosphohydrolase - genetics (3) 3
solid tumors (3) 3
vascular endothelial growth factor (3) 3
abiraterone (2) 2
adjuvant chemotherapy (2) 2
anthracyclines - therapeutic use (2) 2
biomarkers, tumor - metabolism (2) 2
breast neoplasms - genetics (2) 2
breast neoplasms - immunology (2) 2
breast-cancer (2) 2
cancer patients (2) 2
cancer therapies (2) 2
carcinoma (2) 2
case-control studies (2) 2
castration (2) 2
castration resistance (2) 2
cell biology (2) 2
cell lines (2) 2
cell transformation, neoplastic - genetics (2) 2
cell-free dna (2) 2
child, preschool (2) 2
circulating tumor dna (2) 2
cluster (2) 2
cyclophosphamide (2) 2
disease progression (2) 2
double-blind (2) 2
doxorubicin (2) 2
drug administration schedule (2) 2
endothelial growth-factor (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e20654 - e20654
Journal Article
Breast cancer research : BCR, ISSN 1465-5411, 2014, Volume 16, Issue 1, pp. 488 - 488
Journal Article
Nature Genetics, ISSN 1061-4036, 07/2013, Volume 45, Issue 7, pp. 739 - 746
Journal Article
Journal Article
Nature Genetics, ISSN 1061-4036, 02/2018, Volume 50, Issue 2, pp. 206 - 218
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2018, Volume 13, Issue 4, p. e0194638
Background Angiogenesis is a key process for tumor progression and a target for treatment. However, the regulation of breast cancer angiogenesis and its... 
CELLS | THERAPY | NEOADJUVANT CHEMOTHERAPY | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | TUMOR ANGIOGENESIS | MICRORNAS | CLUSTER | EXPRESSION | DOCETAXEL | ENDOTHELIAL GROWTH-FACTOR | MicroRNAs - antagonists & inhibitors | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | MicroRNAs - metabolism | Vascular Endothelial Growth Factor A - metabolism | MCF-7 Cells | Angiogenesis Inhibitors - therapeutic use | Biomarkers, Tumor - metabolism | Female | Neoadjuvant Therapy | Retrospective Studies | Vascular Endothelial Growth Factor A - pharmacology | Databases, Factual | Transcriptome - drug effects | Breast Neoplasms - blood supply | Breast Neoplasms - drug therapy | Platelet-Derived Growth Factor - metabolism | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Antagomirs - metabolism | MicroRNA | Physiological aspects | Development and progression | Genetic aspects | Breast cancer | Research | Neovascularization | Biotechnology | Estrogens | Oncology | Metastasis | Drug resistance | Assaying | Cancer therapies | Angiogenesis | Breast carcinoma | Transfection | Clusters | Bioindicators | Pretreatment | Conditioning | Vascular endothelial growth factor | Growth factors | Purification | Hematology | Internal medicine | Invasiveness | MiRNA | Blood vessels | Tumor cell lines | Gene expression | Patients | Endothelial cells | Chemotherapy | Ribonucleic acids | Antiangiogenics | MicroRNAs | Medical prognosis | Cell lines | Biomarkers | Breast | Microvasculature | In vitro methods and tests | Tumors | Cancer
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 53, pp. 79 - 97
Journal Article
Nature communications, ISSN 2041-1723, 02/2019, Volume 10, Issue 1, pp. 636 - 17
PTEN is a lipid phosphatase that antagonizes the PI3K/AKT pathway and is recognized as a major dose-dependent tumor suppressor. The cellular mechanisms that... 
SURVIVAL | INACTIVATION | FORKHEAD TRANSCRIPTION FACTOR | GENE | PHOSPHATASE | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | CONTACT INHIBITION | NUCLEAR EXPORT | EXPRESSION | PROGRESSION | Stability | Transcription | Lipids | AKT protein | 1-Phosphatidylinositol 3-kinase | Metastases | Tumor suppressor genes | Forkhead protein | Feedforward | Localization | PTEN protein | Tumors | Cancer
Journal Article